EXPERT OPINION ON INVESTIGATIONAL DRUGS

Edit Your Profile

EXPERT OPINION ON INVESTIGATIONAL DRUGS Journal

publication venue for

Entinostat (SNDX-275) for the treatment of non-small cell lung cancer. 24:1101-1109. 2015
BIBF 1120/nintedanib: A new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer. 22:1081-1088. 2013
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer 2016
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 2015

category

PHARMACOLOGY & PHARMACY Category

International Standard Serial Number (ISSN)

1354-3784

Electronic International Standard Serial Number (EISSN)

1744-7658

journal abbreviation

EXPERT OPIN INV DRUG